Spring 2007 - Purdue College of Pharmacy - Purdue University

Purdue Pharmacy Vision
The vision of the Purdue University School of Pharmacy and Pharmaceutical Sciences
is to be the preeminent school of pharmacy in North America. We will build on the
strengths of the School and Purdue University to launch specific initiatives
that will enable us to be recognized as the pharmacy program
with the highest impact on health care. These initiatives
will be developed within the triad of Purdue’s
mission as a research intensive,
land-grant university.
Discovery Three research initiatives will
be launched: First, the School will partner with the
Regenstrief Center for Health Care Engineering and
the Industrial Engineering program at Purdue to create
a unique research agenda focused on a systems engineering
model for drug distribution and administration from
the point of medication production to administration to
the patient. The first arm of this initiative will focus on
developing systems of distribution and administration
that minimize medication errors.
The second arm will merge Purdue’s strengths in
Industrial Pharmacy and Engineering, as well as the
technological resources at Purdue’s Discovery Park, to
address the growing global problem of counterfeit drugs.
We believe this latter problem must be addressed within
the context of a systems approach that addresses drug
distribution from the point of production to the patient.
We will also launch an initiative designed to develop
integrated, predictive models for pharmaceutical processing.
This initiative, building on the resources of the
Purdue Center for Pharmaceutical Processing Research
and the Engineering Research Center, will aim to reduce
the time from discovery to full scale production for
pharmaceutical products.
An additional initiative will focus on merging the
School’s strengths in industrial pharmacy and cancer
drug discovery to develop a
nanomedicine program focused
on targeted delivery of therapies
for the treatment of cancer.
This initiative will leverage the
resources in the Purdue Cancer
Center, the Birck Nanotechnology
Center, the Oncological
Sciences Center, and the School
of Biomedical Engineering; as
well as the companion animal
disease model program in the
College of Veterinary Medicine.
Learning We will develop inovative practice
models to take advantage of the high accessibility of
community pharmacists to provide early detection of
adverse drug reactions and outpatient interventions.
These practice models will create sites to train a new
generation of community pharmacists to recognize and
manage adverse drug events, with the goal of reducing
the estimated 700,000 annual emergency room visits
related to adverse drug reactions that occur in the U.S.
Engagement We will create pharmacy schoolbased
team of specialists that can respond to significant
medication error events in Indiana health care institutions
to perform a systems analysis of the event and provide
specific system-based recommendations to prevent
recurrences. It is anticipated that student engagement in
this initiative will provide a valuable training model for
a new generation of pharmacists. Once established, we
will seek to transfer this model nationwide.
By accomplishing this vision, the School of Pharmacy
and Pharmaceutical Sciences will improve the utilization
of the most widely accessible health care professionals
(pharmacists), impact health care delivery in the State of
Indiana and nationwide, develop new therapeutic approaches
for the treatment of cancer, promote economic
development through new technology, and establish its
place as the premier school of pharmacy in the nation.
The unique alliance with Discovery Park, the Regenstrief
Center for Health Care Engineering, and the Purdue
Health Care Technical Assistance Program will create
a one-of-a-kind educational, research, and engagement
agenda for training pharmacists for the 21st century.
Purdue University, Butler University, and Lilly Endowment representatives pose during the announcement of the
$50 million in gifts. L to R: Craig Svensson, Dean, Purdue University College of Pharmacy, Nursing and Health Sciences;
Tim McGinley, Purdue University Chair of the Board of Trustees; Martin Jischke, Purdue University President; N. Clay
Robbins, Lilly Endowment President; Sara Cobb, Lilly Endowment Vice President the PURDUE of Education; pharmacist Bobby n SPRING Fong, Butler 2007
University President; Mary Andritz, Dean, Butler University College of Pharmacy and Health Sciences; and John Dunn,
Butler University Chair of the Board of Trustees
3